SQZ Biotechnologies to Present at Upcoming Investor Conferences
04 5월 2022 - 5:30AM
Business Wire
SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full
potential of cell therapies for multiple therapeutic areas, today
announced that Armon Sharei, Ph.D., Chief Executive Officer and
Founder of SQZ Biotechnologies, will present at the Bank of America
Securities 2022 Healthcare Conference on May 10, in Las Vegas,
Nevada and at the H.C. Wainwright Global Investment Conference on
May 25, in Miami, Florida. Presentation times and webcast
information are available below.
PRESENTATION DETAILS
Tuesday, May 10 Bank of America Securities 2022
Healthcare Conference 5:00-5:30 p.m. ET / 2:00-2:30 p.m. PT
Webcast
Wednesday, May 25 H.C. Wainwright Global Investment
Conference 9:30-10:00 a.m. ET Webcast
Conference webcast details and the company’s most recent
corporate overview presentation will be available on the Investors
section of the SQZ website. Replays will be available for 90
days.
About SQZ Biotechnologies
SQZ Biotechnologies Company is a clinical-stage biotechnology
company focused on unlocking the full potential of cell therapies
for patients around the world and has active programs in oncology,
autoimmune and infectious diseases, as well as additional
exploratory initiatives to support future pipeline growth. The
company’s proprietary Cell Squeeze® technology offers the unique
ability to deliver multiple biological materials into many cell
types to engineer what we believe can be a broad range of potential
therapeutics. With demonstrated production timelines under 24 hours
and the opportunity to eliminate preconditioning and lengthy
hospital stays, our approach could significantly broaden the
therapeutic range and accessibility of cell therapies. The
company’s first therapeutic applications seek to generate
target-specific immune responses, both in activation for the
treatment of solid tumors and infectious diseases, and in immune
tolerance for the treatment of autoimmune diseases. For more
information, please visit www.sqzbiotech.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220503005837/en/
Investor Contact: Mike Kaiser
michael.kaiser@sqzbiotech.com 857-760-0398 Media Contact:
John Lacey john.lacey@sqzbiotech.com 781-392-5514
SQZ Biotechnologies (NYSE:SQZ)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
SQZ Biotechnologies (NYSE:SQZ)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024